Enovis Corp
ENOV26.290USD
-4.570-14.81%
Handelsschluss 07/18, 16:00（ET）Kurse um 15 Minuten verzögert
1.50BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Enovis Corp Unternehmen
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Unternehmensinformationen
BörsenkürzelENOV
Name des UnternehmensEnovis Corp
IPO-datumMay 08, 2008
Gegründet am1998
CEOMr. Damien Mcdonald
Anzahl der mitarbeiter7367
WertpapierartOrdinary Share
GeschäftsjahresendeMay 08
Addresse2711 Centerville Road
StadtWILMINGTON
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl19808
Telefon13022529160
Websitehttps://www.enovis.com/
BörsenkürzelENOV
IPO-datumMay 08, 2008
Gegründet am1998
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
104.51K
+18.11%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
96.30K
--
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
36.11K
+90.73%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
10.52K
+168.36%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
10.52K
+168.36%
Mr. Philip A. Okala
Mr. Philip A. Okala
Independent Director
Independent Director
--
--
Ms. Angela S. Lalor
Ms. Angela S. Lalor
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
104.51K
+18.11%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
96.30K
--
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
36.11K
+90.73%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
International Reconstructive
148.37M
26.55%
U.S. Reconstructive
137.88M
24.67%
U.S. Bracing & Support
115.09M
20.59%
International P&R
90.88M
16.26%
U.S. Other P&R
66.62M
11.92%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
International Reconstructive
148.37M
26.55%
U.S. Reconstructive
137.88M
24.67%
U.S. Bracing & Support
115.09M
20.59%
International P&R
90.88M
16.26%
U.S. Other P&R
66.62M
11.92%
Aktionärsstatistik
Aktualisiert: Thu, Jul 10
Aktualisiert: Thu, Jul 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.41%
The Vanguard Group, Inc.
10.64%
American Century Investment Management, Inc.
6.17%
Davenport Asset Management
5.38%
Dimensional Fund Advisors, L.P.
5.12%
Other
61.27%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.41%
The Vanguard Group, Inc.
10.64%
American Century Investment Management, Inc.
6.17%
Davenport Asset Management
5.38%
Dimensional Fund Advisors, L.P.
5.12%
Other
61.27%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
46.99%
Investment Advisor
45.59%
Hedge Fund
7.67%
Research Firm
4.24%
Individual Investor
1.55%
Bank and Trust
1.35%
Pension Fund
1.15%
Family Office
0.05%
Sovereign Wealth Fund
0.05%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
630
68.25M
119.48%
-3.27M
2025Q1
646
68.39M
119.73%
-3.70M
2024Q4
637
64.20M
113.02%
-5.55M
2024Q3
613
62.53M
111.92%
-6.94M
2024Q2
617
64.91M
118.38%
-5.04M
2024Q1
651
62.70M
114.40%
-9.13M
2023Q4
661
61.64M
112.95%
-6.99M
2023Q3
653
60.52M
110.96%
-10.76M
2023Q2
641
59.95M
109.96%
-8.07M
2023Q1
643
57.38M
105.33%
-9.99M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
6.52M
11.41%
+1.67M
+34.39%
Mar 31, 2025
The Vanguard Group, Inc.
6.08M
10.64%
-7.15K
-0.12%
Mar 31, 2025
American Century Investment Management, Inc.
3.52M
6.17%
+369.48K
+11.71%
Mar 31, 2025
Davenport Asset Management
3.07M
5.38%
-206.82K
-6.31%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.93M
5.12%
+27.89K
+0.96%
Mar 31, 2025
Royce Investment Partners
2.49M
4.36%
+20.23K
+0.82%
Mar 31, 2025
State Street Global Advisors (US)
1.89M
3.32%
+162.41K
+9.37%
Mar 31, 2025
Diamond Hill Capital Management Inc.
1.87M
3.28%
-918.91K
-32.92%
Mar 31, 2025
Hood River Capital Management LLC
1.44M
2.53%
+781.15K
+118.10%
Mar 31, 2025
River Road Asset Management, LLC
1.39M
2.44%
+153.53K
+12.40%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sun, Jul 6
Aktualisiert: Sun, Jul 6
Name
Anteil
SPDR S&P Health Care Equipment ETF
1.7%
Invesco S&P SmallCap Health Care ETF
1.27%
Invesco S&P SmallCap 600 Pure Value ETF
0.53%
VictoryShares US Small Mid Cap Value Momentum ETF
0.3%
iShares S&P Small-Cap 600 Value ETF
0.29%
SPDR S&P 600 Small Cap Value ETF
0.28%
First Trust Small Cap Growth AlphaDEX Fund
0.28%
iShares U.S. Medical Devices ETF
0.2%
Avantis US Small Cap Equity ETF
0.2%
DFA Dimensional US Small Cap Value ETF
0.18%
Mehr Anzeigen
SPDR S&P Health Care Equipment ETF
Anteil1.7%
Invesco S&P SmallCap Health Care ETF
Anteil1.27%
Invesco S&P SmallCap 600 Pure Value ETF
Anteil0.53%
VictoryShares US Small Mid Cap Value Momentum ETF
Anteil0.3%
iShares S&P Small-Cap 600 Value ETF
Anteil0.29%
SPDR S&P 600 Small Cap Value ETF
Anteil0.28%
First Trust Small Cap Growth AlphaDEX Fund
Anteil0.28%
iShares U.S. Medical Devices ETF
Anteil0.2%
Avantis US Small Cap Equity ETF
Anteil0.2%
DFA Dimensional US Small Cap Value ETF
Anteil0.18%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
Datum
Art
Verhältnis
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
Mar 18, 2022
Merger
3<1
